Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In a Phase 3 obesity trial, people taking the highest retatrutide dose lost a large amount of weight on average
Benefits Needle-free alternative No injections required Supports weight management Helps regulate appetite and reduce cravings Aids in blood sugar regulation May help improve glucose levels Enhances metabolic function Supports overall health and weight loss goals
When to seek medical help: Contact your GP promptly if you experience persistent loin pain, visible blood in urine, or pain during urination
The use of hydroxychloroquine in COVID-19-positive patients still needs further clinical evaluation
Second Generation: Tirzepatide (GLP-1 + GIP) Tirzepatide (Mounjaro/Zepbound, Eli Lilly) is a dual GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, the first approved dual incretin agonist
As of 2026, cagrilintide is not FDA approved for any indication
US$ 25.55
US$ 28.95
US$ 28.63
US$ 21.74
